G6PD deficiency: a classic example of pharmacogenetics with on-going clinical implications
about
Challenges for malaria elimination in BrazilEvaluation of antimalarial activity and toxicity of a new primaquine prodrugGlucose-6-Phosphate Dehydrogenase Deficiency and Haemoglobin Drop after Sulphadoxine-Pyrimethamine Use for Intermittent Preventive Treatment of Malaria during Pregnancy in Ghana - A Cohort StudyBig Data in Healthcare - Defining the Digital Persona through User Contexts from the Micro to the Macro. Contribution of the IMIA Organizational and Social Issues WGThe challenges of introducing routine G6PD testing into radical cure: a workshop report.Glucose-6-phosphate dehydrogenase deficiency and the risk of malaria and other diseases in children in Kenya: a case-control and a cohort study.Optimizing the programmatic deployment of the anti-malarials artemether-lumefantrine and dihydroartemisinin-piperaquine using pharmacological modelling.Using G6PD tests to enable the safe treatment of Plasmodium vivax infections with primaquine on the Thailand-Myanmar border: A cost-effectiveness analysis.Malaria in Brazil, Colombia, Peru and Venezuela: current challenges in malaria control and elimination.Deciphering next-generation pharmacogenomics: an information technology perspective.Dapsone induced hemolysis in a patient with ANCA associated glomerulonephritis and normal G6PD level and implications for clinical practice: case report and review of the literature.Performance of BinaxNOW G6PD deficiency point-of-care diagnostic in P. vivax-infected subjects.Healing the orphaned heart: heart failure in a patient with glucose-6-phosphate dehydrogenase deficiency.G6PD Deficiency and Hemoglobinopathies: Molecular Epidemiological Characteristics and Healthy Effects on Malaria Endemic Bioko Island, Equatorial Guinea.Risks of Hemolysis in Glucose-6-Phosphate Dehydrogenase Deficient Infants Exposed to Chlorproguanil-Dapsone, Mefloquine and Sulfadoxine-Pyrimethamine as Part of Intermittent Presumptive Treatment of Malaria in InfantsGlucose-6-phosphate dehydrogenase deficiency among malaria patients of Honduras: a descriptive study of archival blood samples.An optimised age-based dosing regimen for single low-dose primaquine for blocking malaria transmission in CambodiaA Comparison of Three Quantitative Methods to Estimate G6PD Activity in the Chittagong Hill Tracts, Bangladesh.Haemolysis in G6PD Heterozygous Females Treated with Primaquine for Plasmodium vivax Malaria: A Nested Cohort in a Trial of Radical Curative Regimens.CYP2C19 drug-drug and drug-gene interactions in ED patients.Safety of a single low-dose of primaquine in addition to standard artemether-lumefantrine regimen for treatment of acute uncomplicated Plasmodium falciparum malaria in TanzaniaMolecular Heterogeneity of Glucose-6-Phosphate Dehydrogenase Deficiency in Burkina Faso: G-6-PD Betica Selma and Santamaria in People with Symptomatic Malaria in Ouagadougou.Development of a pharmacovigilance safety monitoring tool for the rollout of single low-dose primaquine and artemether-lumefantrine to treat Plasmodium falciparum infections in Swaziland: a pilot study.Rare hereditary red blood cell enzymopathies associated with hemolytic anemia - pathophysiology, clinical aspects, and laboratory diagnosis.Pyridine Dinucleotides from Molecules to Man.Safe fluoroquinolones prophylaxis in blood cancer patients with chemotherapy-induced neutropenia and Glucose-6-Phosphate-Dehydrogenase deficiency.A Review of Pharmacogenetics of Antimalarials and Associated Clinical Implications.National G6PD neonatal screening program in Gaza Strip of Palestine: rationale, challenges and recommendations.Asian G6PD-Mahidol Reticulocytes Sustain Normal Plasmodium Vivax Development.What has passed is prolog: new cellular and physiological roles of G6PD.Collaborative Counseling Considerations for Pharmacogenomic Tests.Hemolytic Potential of Tafenoquine in Female Volunteers Heterozygous for Glucose-6-Phosphate Dehydrogenase (G6PD) Deficiency (G6PD Mahidol Variant) versus G6PD-Normal Volunteers.Field Trial of the CareStart Biosensor Analyzer for the Determination of Glucose-6-Phosphate Dehydrogenase Activity in Haiti.Comparison of Spectrophotometry, Chromate Inhibition, and Cytofluorometry Versus Gene Sequencing for Detection of Heterozygously Glucose-6-Phosphate Dehydrogenase-Deficient Females.Glucose-6-phosphate dehydrogenase deficiency and risk of invasive fungal disease in patients with acute myeloid leukemia.Primaquine-thiazolidinones block malaria transmission and development of the liver exoerythrocytic forms.A rare disorder or not? How a child with jaundice changed a nationwide regimen in the Netherlands.Caring for Glucose-6-Phosphate Dehydrogenase (G6PD)-Deficient Patients: Implications for Pharmacy.Impaired embryonic development in glucose-6-phosphate dehydrogenase-deficient Caenorhabditis elegans due to abnormal redox homeostasis induced activation of calcium-independent phospholipase and alteration of glycerophospholipid metabolismImmune Thrombocytopenia Resolved by Eltrombopag in a Carrier of Glucose-6-Phosphate Dehydrogenase Deficiency.
P2860
Q26315456-47CF6653-8D87-44BB-9699-65C523227A67Q28542047-48797605-8E3C-4F25-AD0C-F5F878F755F3Q28547654-806A3FDC-26C0-4DD2-B92A-D5D7577D9FB9Q28652525-3F488826-E58A-4AE5-BDBA-F462E7D92B24Q30666192-9CFEEB91-846A-4861-983F-941A443EA8B7Q31075666-EC8AB4EB-AF15-473E-B745-D82F137FCE01Q33678483-6A938007-9783-47ED-ACFA-296CCFAD4FE7Q33769314-F8D4AE1C-0A5D-42FE-97F5-99DFB8ED9EA2Q33870033-38C6D708-9ECD-479F-AFAF-7BFBD6312DF2Q33987606-6D8A51F6-5664-4CF5-BB8A-072A7A0FAAB2Q35008095-1F7CD97B-4D40-4370-B5F5-3D810464EF62Q35140594-ED78FC03-49D4-4692-B402-268B47FA7481Q35203785-C3EE33D7-E096-483D-93EC-AB2C7B772CC9Q35542748-C108CB7A-4322-4FBC-A660-76851997C58FQ35850290-347E8427-910B-40DE-B883-9D4B9A773BF6Q35927594-F4AF92E4-DF79-49C0-BC9E-4E70EFE28F4BQ36175374-1EEC2151-65CA-4EBD-972E-853CA64A7E79Q36259682-3FEDC6EB-2C11-43F7-9ABB-78298EF324AEQ36272772-7A0E6620-74D9-4EC3-8E44-87E9F92E0F21Q36930041-923B8889-A44A-445E-96F6-C1F02424C09CQ36991071-B46909FD-9793-4CDB-9123-0E8AB307329AQ37055399-001A0D90-A2F7-4D8E-8E7C-B38FCFA09BDEQ37119572-E0D78532-90B5-4605-AA78-B7622C14BF3DQ38205957-47E84725-5EF0-4E28-A7DD-A23C0FF02D2EQ38668667-F05FFCCD-890A-474E-878A-5C3307591C8EQ38734836-11748A17-1FC2-40E1-AF16-5EB94D15A5ECQ38772466-CD087C7E-1182-4E13-882E-165FF7C69D5AQ38804223-C3C9F94E-CA2C-4296-B796-B4BB8E67EA82Q38890746-B87995F7-35EF-460B-B978-0AD5333187F7Q38967640-48E13209-0E46-41B4-B297-E937FE672AD7Q39411218-A9B05F02-D926-47D3-9ADD-AF9D14A24023Q39413284-2802B041-7DA4-4961-9108-459B56ECE163Q39587294-DF449F0C-3DE9-4D34-8DAA-C593CC1580DBQ40043624-CFD9C1C8-206D-401E-82D8-183F7F69B72AQ40254512-E25C7F0B-D9DA-41CD-B3C2-8213660BC07DQ40300583-561BDCE5-5ABE-48C2-8F3E-9766902DAD80Q42055039-7D98E3C5-2986-41AC-85E9-AF7265242DD2Q42180512-71FC9BFC-9A23-4CA3-BA3D-711F1584D934Q42292373-34B0D342-E94D-4C08-B394-4DB767BF6AE2Q42937780-9E101328-BF57-4E7F-9D35-25198A4CCC29
P2860
G6PD deficiency: a classic example of pharmacogenetics with on-going clinical implications
description
2014 nî lūn-bûn
@nan
2014 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
G6PD deficiency: a classic exa ...... on-going clinical implications
@ast
G6PD deficiency: a classic exa ...... on-going clinical implications
@en
G6PD deficiency: a classic exa ...... on-going clinical implications
@nl
type
label
G6PD deficiency: a classic exa ...... on-going clinical implications
@ast
G6PD deficiency: a classic exa ...... on-going clinical implications
@en
G6PD deficiency: a classic exa ...... on-going clinical implications
@nl
prefLabel
G6PD deficiency: a classic exa ...... on-going clinical implications
@ast
G6PD deficiency: a classic exa ...... on-going clinical implications
@en
G6PD deficiency: a classic exa ...... on-going clinical implications
@nl
P2860
P3181
P356
P1476
G6PD deficiency: a classic exa ...... on-going clinical implications
@en
P2093
Elisa Seneca
P2860
P304
P356
10.1111/BJH.12665
P407
P5008
P577
2014-02-01T00:00:00Z